|
Dr. William E. Pullman joined Dyax as our Executive Vice President and Chief Development Officer in October 2007. In this position, Dr. Pullman is responsible for overseeing the clinical, regulatory and program management departments. Previously, Dr. Pullman served as Senior Vice President and Chief Medical Officer at Cubist Pharmaceuticals. Prior to that, he served as Senior Vice President, Exploratory Development at Transform Pharmaceuticals. From 2001 to 2005, he filled various senior management positions at Sanofi-Aventis and from 1995 to 2001 held multiple director level positions of increasing responsibility at Eli Lilly and Company. He began his career at Pfizer as a clinical pharmacologist. Dr. Pullman received his Ph.D. from Australian National University and is a Fellow of the Royal Australasian College of Physicians (F.R.A.C.P.). | 